时代在变:2004至2018年治疗的动脉瘤性蛛网膜下腔出血患者复杂性增加
该回顾性研究分析了单中心1248例动脉瘤性蛛网膜下腔出血患者,发现年病例数从2004年123例降至2018年75例(P<0.001),患者平均Charlson共病指数呈线性上升(R²=0.539,P<0.001),而院内死亡率无变化(R²=0.220,P=0.24)。2012至2015年间,本中心患者平均CCI为2.1(标准差2.0),显著高于本地区低容量医院的1.8(标准差1.6)。作者认为这些趋势可能归因于小容量医院神经介入服务可及性增加,从而能治疗更健康的患者。
要点
- 年aSAH住院病例数从2004年123例显著下降至2018年75例(P<0.001)。
- 患者平均Charlson共病指数呈线性上升趋势(R²=0.539,P<0.001),院内死亡率无变化(R²=0.220,P=0.24)。
- 2012至2015年本中心患者平均CCI 2.1(标准差2.0)显著高于低容量医院的1.8(标准差1.6)。
核心结论
- 研究期间aSAH住院患者数量减少,近期入院患者既存共病和神经复杂性更重;这些趋势可能归因于小容量医院神经介入服务可及性增加,从而能治疗更健康的患者。
研究设计与样本
- 回顾性综述本院治疗的动脉瘤性蛛网膜下腔出血患者,并进行趋势分析;同时查询全国住院患者样本(NIS)以比较本中心患者与本普查区内低容量医院(年aSAH<20例)患者的CCI评分。
主要发现
- 共1248例aSAH住院患者接受治疗,其中血管内治疗489例(39%),显微手术759例(61%)。
- 年aSAH病例数从2004年123例下降至2018年75例(P<0.001)。
- 患者平均CCI评分呈线性上升趋势(R²=0.539,P<0.001),院内死亡率无变化(R²=0.220,P=0.24)。
- 2012至2015年间,本普查区内治疗aSAH的小容量医院患者平均CCI为1.8(标准差1.6),显著低于本中心患者的2.1(标准差2.0)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nationwide study results have suggested varying trends in the incidence of aneurysmal subarachnoid hemorrhage (aSAH) over time. Herein, trends over time for aSAH treated at a quaternary care center are compared with low-volume hospitals. METHODS: Cases were retrospectively reviewed for patients with aSAH treated at our institution. Trend analyses were performed on the number of aSAH hospitalizations, treatment type, Charlson Comorbidity Index (CCI), Hunt and Hess grade, aneurysm location, aneurysm type, and in-hospital mortality. The National Inpatient Sample (NIS) was queried to compare the CCI scores of our patients with those of patients in low-volume hospitals (<20 aSAH/year) in our census division. RESULTS: Some 1248 patients (321 during 2004-2006; 927 during 2008-2018) hospitalized with aSAH were treated with endovascular therapy (489, 39%) or microsurgery (759, 61%). A significant downtrend in the annual aSAH caseload occurred (123 patients in 2004, 75 in 2018, P < 0.001). A linear uptrend was observed for the mean CCI score of patients (R 2 = 0.539, P < 0.001), with no change to in-hospital mortality (R 2 = 0.220, P = 0.24). Mean (standard deviation) CCI for small-volume hospitals treating aSAH within our division was significantly lower than that of our patient population (1.8 [1.6] vs 2.1 [2.0]) for 2012-2015. CONCLUSIONS: A decreasing number of patients were hospitalized with aSAH throughout the study. Compared with patients with aSAH admitted in 2004, those admitted more recently were sicker in terms of preexisting comorbidity and neurologic complexity. These trends could be attributable to the increasing availability of neurointerventional services at smaller-volume hospitals capable of treating healthier patients.
引用
- Catapano JS, Srinivasan VM, Labib MA, et al. The Times They Are a-Changin': Increasing Complexity of Aneurysmal Subarachnoid Hemorrhages in Patients Treated from 2004 to 2018. World Neurosurg. 2022. PMID: 35092812. doi:10.1016/j.wneu.2022.01.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。